Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics
Abstract Heat shock protein 90 (HSP90) inhibition is an attractive strategy for cancer treatment. Several HSP90 inhibitors have shown promising effects in clinical oncology trials. However, little is known about HSP90 inhibition-mediated bladder cancer therapy. Here, we report a quantitative proteom...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d315dc00c8384dfc8ae699ecec61f833 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d315dc00c8384dfc8ae699ecec61f833 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d315dc00c8384dfc8ae699ecec61f8332021-12-02T16:07:02ZProteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics10.1038/s41598-017-00143-62045-2322https://doaj.org/article/d315dc00c8384dfc8ae699ecec61f8332017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00143-6https://doaj.org/toc/2045-2322Abstract Heat shock protein 90 (HSP90) inhibition is an attractive strategy for cancer treatment. Several HSP90 inhibitors have shown promising effects in clinical oncology trials. However, little is known about HSP90 inhibition-mediated bladder cancer therapy. Here, we report a quantitative proteomic study that evaluates alterations in protein expression and histone post-translational modifications (PTMs) in bladder carcinoma in response to HSP90 inhibition. We show that 5 HSP90 inhibitors (AUY922, ganetespib, SNX2112, AT13387, and CUDC305) potently inhibited the proliferation of bladder cancer 5637 cells in a dose- and time-dependent manner. Our proteomic study quantified 518 twofold up-regulated and 811 twofold down-regulated proteins common to both AUY922 and ganetespib treatment. Bioinformatic analyses revealed that those differentially expressed proteins were involved in multiple cellular processes and enzyme-regulated signaling pathways, including chromatin modifications and cell death-associated pathways. Furthermore, quantitative proteome studies identified 14 types of PTMs with 93 marks on the core histones, including 34 novel histone marks of butyrylation, citrullination, 2-hydroxyisobutyrylation, methylation, O-GlcNAcylation, propionylation, and succinylation in AUY922- and ganetespib-treated 5637 cells. Together, this study outlines the association between proteomic changes and histone PTMs in response to HSP90 inhibitor treatment in bladder carcinoma cells, and thus intensifies the understanding of HSP90 inhibition-mediated bladder cancer therapeutics.Qingdi Quentin LiJian-Jiang HaoZheng ZhangL. Spencer KraneKai H. HammerichThomas SanfordJane B. TrepelLen NeckersPiyush K. AgarwalNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-20 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Qingdi Quentin Li Jian-Jiang Hao Zheng Zhang L. Spencer Krane Kai H. Hammerich Thomas Sanford Jane B. Trepel Len Neckers Piyush K. Agarwal Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
description |
Abstract Heat shock protein 90 (HSP90) inhibition is an attractive strategy for cancer treatment. Several HSP90 inhibitors have shown promising effects in clinical oncology trials. However, little is known about HSP90 inhibition-mediated bladder cancer therapy. Here, we report a quantitative proteomic study that evaluates alterations in protein expression and histone post-translational modifications (PTMs) in bladder carcinoma in response to HSP90 inhibition. We show that 5 HSP90 inhibitors (AUY922, ganetespib, SNX2112, AT13387, and CUDC305) potently inhibited the proliferation of bladder cancer 5637 cells in a dose- and time-dependent manner. Our proteomic study quantified 518 twofold up-regulated and 811 twofold down-regulated proteins common to both AUY922 and ganetespib treatment. Bioinformatic analyses revealed that those differentially expressed proteins were involved in multiple cellular processes and enzyme-regulated signaling pathways, including chromatin modifications and cell death-associated pathways. Furthermore, quantitative proteome studies identified 14 types of PTMs with 93 marks on the core histones, including 34 novel histone marks of butyrylation, citrullination, 2-hydroxyisobutyrylation, methylation, O-GlcNAcylation, propionylation, and succinylation in AUY922- and ganetespib-treated 5637 cells. Together, this study outlines the association between proteomic changes and histone PTMs in response to HSP90 inhibitor treatment in bladder carcinoma cells, and thus intensifies the understanding of HSP90 inhibition-mediated bladder cancer therapeutics. |
format |
article |
author |
Qingdi Quentin Li Jian-Jiang Hao Zheng Zhang L. Spencer Krane Kai H. Hammerich Thomas Sanford Jane B. Trepel Len Neckers Piyush K. Agarwal |
author_facet |
Qingdi Quentin Li Jian-Jiang Hao Zheng Zhang L. Spencer Krane Kai H. Hammerich Thomas Sanford Jane B. Trepel Len Neckers Piyush K. Agarwal |
author_sort |
Qingdi Quentin Li |
title |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
title_short |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
title_full |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
title_fullStr |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
title_full_unstemmed |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
title_sort |
proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/d315dc00c8384dfc8ae699ecec61f833 |
work_keys_str_mv |
AT qingdiquentinli proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT jianjianghao proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT zhengzhang proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT lspencerkrane proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT kaihhammerich proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT thomassanford proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT janebtrepel proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT lenneckers proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics AT piyushkagarwal proteomicanalysisofproteomeandhistoneposttranslationalmodificationsinheatshockprotein90inhibitionmediatedbladdercancertherapeutics |
_version_ |
1718384808211513344 |